Blog

Guilherme Perini: Would love to hear colleagues from Low- or Middle-Income Countries.

Photo of Guilherme Perini taken from X/Twitter

Oct 3, 2023, 18:07

Guilherme Perini: Would love to hear colleagues from Low- or Middle-Income Countries.

Guilherme Perini, Hematologist at Israelita Albert Einstein Hospital, shared a post by Bishal Gyawali on X/Twitter:

“Do any of the authors actually practice in Low- or Middle-Income Countries? No. I would gladly have as many trials as possible if I could get my patients new and better drugs. But maybe that’s just me. Would love to hear from my colleagues from Low- or Middle-Income Countries.”

Quoting Bishal Gyawali, Medical Oncologist at Queen’s University’s post:

Our new editorial is out today in BMJ Oncology on the globalization of cancer drug trials. Thanks, Kristina Jenei for leading this, and Fabio Moraes for the collaboration.”

For details click here.
Source: Guilherme Perini/Twitter and Bishal Gyawali/Twitter

Bishal Gyawali BMJ Oncology cancer Fabio Moraes Guilherme Perini Israelita Albert Einstein Hospital Kristina Jenei OncoDaily Oncology Queen’s University

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage